Last updated on April 2018

Randomized Double-blind Placebo-Controlled Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold

Brief description of study

This will be a randomized, double-blind, placebo controlled, parallel-group Phase 2 study to evaluate the efficacy of a new formulation of phenylephrine HCl and a currently marketed phenylephrine HCl for relief of nasal congestion in subjects with naturally occurring cold symptoms.

Clinical Study Identifier: NCT03339726

Contact Investigators or Research Sites near you

Start Over

Robert Williams

The Medical Arts Health Research Group
Kelowna, BC Canada

Antonio Del Vicario, MD

Mission Hills Urgent Care Walk in Clinic
Mission, BC Canada

Garry Wallace, MD

Dawson Road Family Medical Clinic
Guelph, ON Canada

Altaf Mawji, MD

Sunningdale Health and Wellness Centre
London, ON Canada

Sean Peterson, MD

Bluewater Clinical Research Group, Inc.
Sarnia, ON Canada

James McKay, MD

NEOMO Research
Sudbury, ON Canada

Lew Pliamm, MD

Canadian Phase Onward, Inc.
Toronto, ON Canada

Iris Gorfinkel, MD

PrimeHealth Clinical Research
Toronto, ON Canada

Ginette Girard, MD

Diex Recherche
Sherbrooke, QC Canada

Ethel Bellavance, MD

Diex Recherche
Victoriaville, QC Canada

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.